ArticleJournal of clinical medicine research2019

Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center.

Seigo Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.